Skip to main content

Advertisement

Log in

BDNF Participates in Chronic Constriction Injury-Induced Neuropathic Pain via Transcriptionally Activating P2X7 in Primary Sensory Neurons

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Neuropathic pain, resulting from the pathological changes of the somatosensory nervous system, remains a severe public health problem worldwide. The effect of treatment targeting neuropathic pain is very limited, as the underlying mechanism of neuropathic pain is largely unknown. In this study, we demonstrated that the expression level of brain-derived neurotrophic factor (BDNF) was remarkably and time-dependently increased in dorsal root ganglion (DRG) neurons. DRG microinjection of BDNF siRNA in DRG ameliorated chronic constriction injury (CCI) induced mechanical, thermal, and cold nociceptive hypersensitivities. Overexpressing BDNF through microinjection of the AAV5-BDNF in DRG caused enhanced responses to basal mechanical, thermal, and cold stimuli in mice exposed to CCI. Mechanically, the P2X7 promoter activity was enhanced by CCI-induced increase of DRG BDNF protein and was involved in the CCI-induced upregulation of DRG P2X7 protein. The overexpression of BDNF also increased P2X7 expression in DRG neurons, which was validated in in vivo and in vitro experiments. BDNF may exert crucial effect via transcriptionally activating the P2X7 gene in primary sensory neurons, since P2X7 acts as a role of endogenous agitator in neuropathic pain and BDNF largely co-expresses with P2X7 in DRG neurons. Therefore, our data provide evidence that BDNF may be a promising therapeutic target for neuropathic pain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data Availability

Data will be made available on reasonable request.

References

  1. Scholz J, Finnerup NB, Attal N, Aziz Q, Baron R, Bennett MI, Benoliel R, Cohen M et al (2019) The IASP classification of chronic pain for ICD-11: chronic neuropathic pain. Pain 160(1):53–59

    Article  Google Scholar 

  2. van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N (2014) Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain 155(4):654–662

    Article  Google Scholar 

  3. Cohen SP, Mao J (2014) Neuropathic pain: mechanisms and their clinical implications. BMJ 348:f7656

    Article  Google Scholar 

  4. St JSE (2018) Advances in understanding nociception and neuropathic pain. J Neurol 265(2):231–238

    Article  Google Scholar 

  5. Thompson SW, Bennett DL, Kerr BJ, Bradbury EJ, McMahon SB (1999) Brain-derived neurotrophic factor is an endogenous modulator of nociceptive responses in the spinal cord. Proc Natl Acad Sci U S A 96(14):7714–7718

    Article  CAS  Google Scholar 

  6. McMahon SB, Cafferty WB (2004) Neurotrophic influences on neuropathic pain. Novartis Found Symp 261: 68–92; discussion 92–102, 149–54

  7. Pezet S, McMahon SB (2006) Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci 29:507–538

    Article  CAS  Google Scholar 

  8. Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, Inoue K, Gravel C, Salter MW et al (2005) BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438(7070):1017–1021

    Article  CAS  Google Scholar 

  9. Ha SO, Kim JK, Hong HS, Kim DS, Cho HJ (2001) Expression of brain-derived neurotrophic factor in rat dorsal root ganglia, spinal cord and gracile nuclei in experimental models of neuropathic pain. Neuroscience 107(2):301–309

    Article  CAS  Google Scholar 

  10. Li YX, Xu Y, Ju D, Lester HA, Davidson N, Schuman EM (1998) Expression of a dominant negative TrkB receptor, T1, reveals a requirement for presynaptic signaling in BDNF-induced synaptic potentiation in cultured hippocampal neurons. Proc Natl Acad Sci U S A 95(18):10884–10889

    Article  CAS  Google Scholar 

  11. Yajima Y, Narita M, Usui A, Kaneko C, Miyatake M, Narita M, Yamaguchi T, Tamaki H et al (2005) Direct evidence for the involvement of brain-derived neurotrophic factor in the development of a neuropathic pain-like state in mice. J Neurochem 93(3):584–594

    Article  CAS  Google Scholar 

  12. MacQueen GM, Ramakrishnan K, Croll SD, Siuciak JA, Yu G, Young LT, Fahnestock M (2001) Performance of heterozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression. Behav Neurosci 115(5):1145–1153

    Article  CAS  Google Scholar 

  13. Kerr BJ, Bradbury EJ, Bennett DL, Trivedi PM, Dassan P, French J, Shelton DB, McMahon SB et al (1999) Brain-derived neurotrophic factor modulates nociceptive sensory inputs and NMDA-evoked responses in the rat spinal cord. J Neurosci 19(12):5138–5148

    Article  CAS  Google Scholar 

  14. Bennett GJ, Xie YK (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33(1):87–107

    Article  Google Scholar 

  15. Zhang J, Liang L, Miao X, Wu S, Cao J, Tao B, Mao Q, Mo K et al (2016) Contribution of the suppressor of variegation 3–9 homolog 1 in dorsal root ganglia and spinal cord dorsal horn to nerve injury-induced nociceptive hypersensitivity. Anesthesiology 125(4):765–778

    Article  CAS  Google Scholar 

  16. Xu JT, Zhao J-Y, Zhao X, Ligons D, Tiwari V, Atianjoh FE, Lee C-Y, Liang L et al (2014) Opioid receptor-triggered spinal mTORC1 activation contributes to morphine tolerance and hyperalgesia. J Clin Invest 124(2):592–603

    Article  CAS  Google Scholar 

  17. Li Z, Gu X, Sun L, Wu S, Liang L, Cao J, Lutz BM, Bekker A et al (2015) Dorsal root ganglion myeloid zinc finger protein 1 contributes to neuropathic pain after peripheral nerve trauma. Pain 156(4):711–721

    Article  CAS  Google Scholar 

  18. Li J, Li D, Zhou H, Wu G, He Z, Liao W, Li Y, Zhi Y (2020) MicroRNA-338–5p alleviates neuronal apoptosis via directly targeting BCL2L11 in APP/PS1 mice. Aging (Albany NY) 12(20):20728–20742

  19. Li J, Guo M, Liu Y, Wu G, Miao L, Zhang J, Zuo Z, Li Y (2019) Both GSK-3β/CRMP2 and CDK5/CRMP2 pathways participate in the protection of dexmedetomidine against propofol-induced learning and memory impairment in neonatal rats. Toxicol Sci kfz135

  20. Li J, Wu G, Song W, Liu Y, Han Z, Shen Z, Li Y (2020) Prophylactic melatonin treatment ameliorated propofol-induced cognitive dysfunction in aged rats. Neurotox Res 39(2):227–239

  21. Tao YX, Rumbaugh G, Wang G-D, Petralia RS, Zhao C, Kauer FW, Tao F, Zhuo M et al (2003) Impaired NMDA receptor-mediated postsynaptic function and blunted NMDA receptor-dependent persistent pain in mice lacking postsynaptic density-93 protein. J Neurosci 23(17):6703–6712

    Article  CAS  Google Scholar 

  22. Zhao X, Tang Z, Zhang H, Atianjoh FE, Zhao J-Y, Liang L, Wang W, Guan X et al (2013) A long noncoding RNA contributes to neuropathic pain by silencing Kcna2 in primary afferent neurons. Nat Neurosci 16(8):1024–1031

    Article  CAS  Google Scholar 

  23. Wu G, Zhou H, Li D, Zhi Y, Liu Y, Li J, Wang F (2020) LncRNA DANCR upregulation induced by TUFT1 promotes malignant progression in triple negative breast cancer via miR-874-3p-SOX2 axis. Exp Cell Res 396(2):112331

    Article  CAS  Google Scholar 

  24. Xie J, Liu S, Wu B, Li G, Rao S, Zou L, Yi Z, Zhang C et al (2017) The protective effect of resveratrol in the transmission of neuropathic pain mediated by the P2X(7) receptor in the dorsal root ganglia. Neurochem Int 103:24–35

    Article  CAS  Google Scholar 

  25. Ge H, Guan S, Shen Y, Sun M, Hao Y, He L, Liu L, Yin C et al (2019) Dihydromyricetin affects BDNF levels in the nervous system in rats with comorbid diabetic neuropathic pain and depression. Sci Rep 9(1):14619

    Article  Google Scholar 

  26. Nijs J, Meeus M, Versijpt J, Moens M, Bos I, Knaepen K, Meeusen R (2015) Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target? Expert Opin Ther Targets 19(4):565–576

    Article  CAS  Google Scholar 

  27. Zhang H, Qian Y-L, Li C, Liu D, Wang L, Wang X-Y, Liu M-J, Liu H et al (2017) Brain-derived neurotrophic factor in the mesolimbic reward circuitry mediates nociception in chronic neuropathic pain. Biol Psychiatry 82(8):608–618

    Article  CAS  Google Scholar 

  28. Skaper SD, Debetto P, Giusti P (2010) The P2X7 purinergic receptor: from physiology to neurological disorders. FASEB J 24(2):337–345

    Article  CAS  Google Scholar 

  29. Burnstock G, Krügel U, Abbracchio MP, Illes P (2011) Purinergic signalling: from normal behaviour to pathological brain function. Prog Neurobiol 95(2):229–274

    Article  CAS  Google Scholar 

  30. Coddou C, Yan Z, Obsil T, Huidobro-Toro JP, Stojilkovic SS (2011) Activation and regulation of purinergic P2X receptor channels. Pharmacol Rev 63(3):641–683

    Article  CAS  Google Scholar 

  31. Yan Z, Khadra A, Sherman A, Stojilkovic SS (2011) Calcium-dependent block of P2X7 receptor channel function is allosteric. J Gen Physiol 138(4):437–452

    Article  CAS  Google Scholar 

  32. Broom DC, Matson DJ, Bradshaw E, Buck ME, Meade R, Coombs S, Matchett M, Ford KK et al (2008) Characterization of N-(adamantan-1-ylmethyl)-5-[(3R-amino-pyrrolidin-1-yl)methyl]-2-chloro-benzamide, a P2X7 antagonist in animal models of pain and inflammation. J Pharmacol Exp Ther 327(3):620–633

    Article  CAS  Google Scholar 

  33. Perez-Medrano A, Donnelly-Roberts DL, Honore P, Hsieh GC, Namovic MT, Peddi S, Shuai Q, Wang Y et al (2009) Discovery and biological evaluation of novel cyanoguanidine P2X(7) antagonists with analgesic activity in a rat model of neuropathic pain. J Med Chem 52(10):3366–3376

    Article  CAS  Google Scholar 

  34. Chessell IP, Hatcher JP, Bountra C, Michel AD, Hughes JP, Green P, Egerton J, Murfin M et al (2005) Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114(3):386–396

    Article  CAS  Google Scholar 

  35. Wang X, Arcuino G, Takano T, Lin J, Peng WG, Wan P, Li P, Xu Q et al (2004) P2X7 receptor inhibition improves recovery after spinal cord injury. Nat Med 10(8):821–827

    Article  CAS  Google Scholar 

Download references

Funding

This work was supported by the Natural Science Foundation of Guangdong Province, China (No.2016A030313251, No.2018A0303130272); and the Science and Technology Planning Project of Guangzhou, China (No. 201707010207).

Author information

Authors and Affiliations

Authors

Contributions

Yi Wu, Zhiwen Shen, and Hui Xu: investigation, methodology, writing-original draft preparation. Kun Zhang: visualization, software. Mingyan Guo: conceptualization, data curation. Fei Wang and Junhua Li: writing-reviewing and editing.

Corresponding authors

Correspondence to Fei Wang or Junhua Li.

Ethics declarations

All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.

Consent to Participate

Not applicable.

Consent for Publication

Not applicable.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, Y., Shen, Z., Xu, H. et al. BDNF Participates in Chronic Constriction Injury-Induced Neuropathic Pain via Transcriptionally Activating P2X7 in Primary Sensory Neurons. Mol Neurobiol 58, 4226–4236 (2021). https://doi.org/10.1007/s12035-021-02410-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-021-02410-0

Keywords

Navigation